Cite Filings / CADL
Feed Companies Filings Check
Sign in

CIK 0001841387

  • Emerging growth company

Candel Therapeutics, Inc.

Sign in to watch
Ticker
CADL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
522214851
Phone
+1 617-916-5445
Business address
117 KENDRICK STREET, SUITE 450, NEEDHAM, MA, 02494
Filings Financials Insiders Search text
All 423 Financials 111 Shareholder Meetings 5 Executive Compensation 99 Insider Trading 202 Beneficial Ownership Interest 23 Business Combinations 87 Public Offerings 30 Mutual Funds and ETFs 5 Others 57
›
Filed in
  1. No filings match these filters. Clear filters
  2. CORRESP Other Correspondence Between Filers and SEC Staff 2021-07-20
  3. CORRESP Other Correspondence Between Filers and SEC Staff 2021-07-20
  4. UPLOAD Other SEC-generated Letter 2021-07-19
  5. CORRESP Other Correspondence Between Filers and SEC Staff 2021-07-16
  6. S-1/A Offering Registration Statement 2021-07-16
  7. UPLOAD Other SEC-generated Letter 2021-07-12
  8. CORRESP Other Correspondence Between Filers and SEC Staff 2021-07-07
  9. S-1 Offering Registration Statement 2021-06-25
  10. UPLOAD Other SEC-generated Letter 2021-04-09
  11. UPLOAD Other SEC-generated Letter 2021-03-15

Page 2 of 2 · 30 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…